Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125.
暂无分享,去创建一个
G. Rustin | W. Oster | J. Ledermann | A. Nelstrop | H. Lambert | R. Coleman | M. Crawford | S. Brown | J. Johnson | H. Evans